GB0718051D0 - Improvements in heterotypic formulations of anticancer drugs - Google Patents

Improvements in heterotypic formulations of anticancer drugs

Info

Publication number
GB0718051D0
GB0718051D0 GB0718051A GB0718051A GB0718051D0 GB 0718051 D0 GB0718051 D0 GB 0718051D0 GB 0718051 A GB0718051 A GB 0718051A GB 0718051 A GB0718051 A GB 0718051A GB 0718051 D0 GB0718051 D0 GB 0718051D0
Authority
GB
United Kingdom
Prior art keywords
heterotypic
formulations
anticancer drugs
anticancer
drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0718051A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0707116A external-priority patent/GB0707116D0/en
Application filed by Individual filed Critical Individual
Publication of GB0718051D0 publication Critical patent/GB0718051D0/en
Ceased legal-status Critical Current

Links

GB0718051A 2007-04-13 2007-09-17 Improvements in heterotypic formulations of anticancer drugs Ceased GB0718051D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0707116A GB0707116D0 (en) 2007-04-13 2007-04-13 A Wide-spectrum chemotheraphy of cancers and bacterial diseases
GB0713426A GB0713426D0 (en) 2007-04-13 2007-07-11 Improvements in anticancer drugs

Publications (1)

Publication Number Publication Date
GB0718051D0 true GB0718051D0 (en) 2007-10-24

Family

ID=38616887

Family Applications (4)

Application Number Title Priority Date Filing Date
GB0716743A Ceased GB0716743D0 (en) 2007-04-13 2007-08-29 Improvements in heterotypic formulations of anticancer drugs
GB0718051A Ceased GB0718051D0 (en) 2007-04-13 2007-09-17 Improvements in heterotypic formulations of anticancer drugs
GB0718208A Ceased GB0718208D0 (en) 2007-04-13 2007-09-19 Improvement in cancer chemotherapy
GB0718539A Ceased GB0718539D0 (en) 2007-04-13 2007-09-24 Improvements in cancer chemotherapy

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB0716743A Ceased GB0716743D0 (en) 2007-04-13 2007-08-29 Improvements in heterotypic formulations of anticancer drugs

Family Applications After (2)

Application Number Title Priority Date Filing Date
GB0718208A Ceased GB0718208D0 (en) 2007-04-13 2007-09-19 Improvement in cancer chemotherapy
GB0718539A Ceased GB0718539D0 (en) 2007-04-13 2007-09-24 Improvements in cancer chemotherapy

Country Status (1)

Country Link
GB (4) GB0716743D0 (en)

Also Published As

Publication number Publication date
GB0716743D0 (en) 2007-10-10
GB0718208D0 (en) 2007-10-31
GB0718539D0 (en) 2007-10-31

Similar Documents

Publication Publication Date Title
IL275854A (en) Pharmaceutical composition and administration thereof
IL276157A (en) Pharmaceutical compositions and related methods of delivery
IL242883B (en) Arylamino- and heteroarylamino-substituted dioxoazolines and pharmaceutical compositions comprising them
HK1164059A1 (en) Compositions for drug administration
SI2154966T1 (en) Benzimidazoles and pharmaceutical compositions thereof
IL206594A (en) Azinone-tetrahydropyridoindole derivatives and pharmaceutical compositions comprising thereof
GB0703966D0 (en) Improvements in or relating to medicinal compositions
GB0703967D0 (en) Improvements in or relating to medicinal compositions
AP2920A (en) Anti-malarial pharmaceutical composition
EP2185112A4 (en) Stabilized therapeutic compositions and formulations
EP2320729A4 (en) Glycoside compounds and pharmaceutical compositions thereof
GB0703933D0 (en) Improvements in or relating to medicinal compositions
IL216361A0 (en) Anti-cancer compound and pharmaceutical composition containing the same
HK1155062A1 (en) Pharmaceutical composition and combined agent
GB0718051D0 (en) Improvements in heterotypic formulations of anticancer drugs
GB0811684D0 (en) Improvements in heterotypic formulations of anticancer drugs
GB201005204D0 (en) Improvements in heterotypic formulations of anticancer drugs
GB0713426D0 (en) Improvements in anticancer drugs
GB0712467D0 (en) In situ delivery of probotic formulations
GB0713093D0 (en) Pharmaceutical formulations
HU0700096D0 (en) Homeopathic pharmaceutical compositions
GB0811599D0 (en) Improvements in anticancer drugs
GB0716003D0 (en) Delivery of drug combinations
GB0810217D0 (en) Pharmaceutical formulations
GB0813031D0 (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)